Similar Search Results

Product differentiation, competition and regulation of new drugs : the case of statins in four European countries

Kanavos, Panos; Costa-Font, Joan; McGuire, Alistair - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 455-465

Persistent link: https://www.econbiz.de/10003543710

Price regulation and relative delays in generic drug adoption

Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Journal of health economics 38 (2014), pp. 1-9

Persistent link: https://www.econbiz.de/10011282079

Regulation effects on the adoption of new medicines

Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Empirical economics : a journal of the Institute for … 49 (2015) 3, pp. 1101-1121

Persistent link: https://www.econbiz.de/10011377336

Does adoption of pharmaceutical innovation respond to changes in the regulatory environment?

Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - In: Applied economic perspectives and policy 34 (2012) 3, pp. 531-553

Persistent link: https://www.econbiz.de/10009721541

Price regulation and relative delays in generic drug adoption

Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Journal of Health Economics 38 (2014) C, pp. 1-9

Increasing the adoption of generic drugs has the potential to improve static efficiency in a health system without harming pharmaceutical innovation. However, very little is known about the timing of generic adoption and diffusion. No prior study has empirically examined the differential launch...

Persistent link: https://www.econbiz.de/10011117216